The renewed momentum in the cryptocurrency space has led to remarkable growth for established companies. Investors are attracted to HNT and Cybro due to their innovative scalability solutions. While these projects are thriving, a dynamic new entrant has emerged: Qubetics ($TICS). With over $1.2 million raised, Qubetics proves it lives up to the hype. This impressive presale kickoff has captured the attention of investors eager for innovative projects that have the potential to reshape the cryptocurrency sector. Stay tuned to explore this cryptocurrency project’s advantages to the blockchain community!
Helium Joins Forces with Ameriband to Expand the Network
Helium just announced that it will work exclusively with American Bandwidth, a preeminent platform for Wi-Fi infrastructure. Helium says this agreement will bring over 100,000 new Data-Only Hotspots of Ameriband to the platform’s total network. The platform shared the specifics of this development on social media. According to Helium, these hotspots quickly increase the service area across the United States by functioning as miniature cell towers. This milestone differs from the conventional telco paradigm in that it does not involve the construction of large, expensive cell towers. It shows how a mobile network can scale quickly and effectively if users power it by expanding coverage. Ameriband’s extensive network is installed in well-known retail establishments, event spaces, office buildings, and supermarket chains in the United States. It will support the Helium Network’s utility.
CYBRO Presale with Interesting Insights
Crypto whales are taking notice of CYBRO as its exclusive token presale rapidly surpasses $3 million. With this state-of-the-art platform, investors may take advantage of unmatched chances to optimise their profits regardless of market conditions. Experts estimate that CYBRO tokens, which are only $0.03 apiece during the presale, might provide a return of 1200%. Prominent cryptocurrency whales and influencers have already shown interest in this unique, cutting-edge initiative, demonstrating their high confidence. Establishing CYBRO’s referral program, which offers 12% from direct referees’ token purchases, 3% from second-level referees, and 2% from third-level referees, is an exciting development. Referees receive double CYBRO Points on their initial deposit with the referral code, and rewards are handed out weekly in USDT.
Experience Smooth dApp Development Process with Qubetics
Qubetics is a Layer-1 blockchain created to tackle major issues facing the sector. One of its most notable applications is QubeQode, a cutting-edge integrated development environment (IDE) that provides an intuitive platform with drag-and-drop components and a code snippet library. This simplifies the process for developers to create blockchain apps.
The platform’s AI-driven development tools make it simple for users with no coding knowledge to construct smart contracts and optimise code. Blockchain technology is now more accessible than ever with QubeQode IDE. Its AI integration improves overall efficiency, code quality, and development speed. Due to its goal of enabling universal access to blockchain technology, Qubetics is now experiencing significant investor interest, as seen by its ongoing crypto token presale. With tokens priced at $0.0132, the third presale round has topped over $1.2 million. Over time, early investors might expect substantial profits.
Conclusion
While Helium and Cybro expand, Qubetics ($TICS) stands tall because of its all-encompassing plan to revolutionise the digital economy. With the QubeQode IDE, the platform provides practical answers to problems encountered during dApp development. With more than $1.2 million collected in presale, Qubetics is headed for mass market acceptance. Join the top crypto presale tokens to be at the forefront of cutting-edge crypto solutions.
With More Information
Qubetics: https://www.qubetics.com/
Telegram: https://t.me/qubetics
Twitter: https://twitter.com/qubetics
Disclaimer: Any information written in this press release does not constitute investment advice. Optimisus does not, and will not endorse any information about any company or individual on this page. Readers are encouraged to do their own research and base any actions on their own findings, not on any content written in this press release. Optimisus is and will not be responsible for any damage or loss caused directly or indirectly by the use of any content, product, or service mentioned in this press release.
